Understanding how toxic chemicals harm the eye
Toxic Mechanisms of Vesicating Chemicals in the Eye
This study is looking at how harmful chemicals from industrial materials can hurt the clear part of your eye, called the cornea, and it aims to understand both the short-term and long-term effects so we can find better ways to help people who have been exposed to these substances.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-10906754 on NIH RePORTER |
What this research studies
This research investigates the harmful effects of toxic industrial materials (TIMs) on the cornea, the clear front part of the eye. It aims to characterize both the immediate and long-term impacts of these chemicals, which can cause severe injuries leading to vision impairment and other complications. By using advanced laboratory techniques, the study will assess how different doses of TIM vapors affect corneal health and recovery. The findings could help improve treatment strategies for individuals exposed to these harmful substances.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced chemical exposure resulting in eye injuries or those at risk of such exposures.
Not a fit: Patients with eye injuries not related to chemical exposure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for patients suffering from chemical-induced eye injuries.
How similar studies have performed: Previous research has shown success in understanding the effects of chemical exposures on eye health, but this specific focus on TIMs is relatively novel.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Mcnutt, Patrick Michael — Wake Forest University Health Sciences
- Study coordinator: Mcnutt, Patrick Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.